Literature DB >> 21257736

Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Mohamed Hashem1, Hanaa El-Karaksy, Mohamed T Shata, Maha Sobhy, Heba Helmy, Suzan El-Naghi, Gehan Galal, Zainab Z Ali, Gamal Esmat, Sayed F Abdelwahab, G Thomas Strickland, Samer S El-Kamary.   

Abstract

BACKGROUND: Cell-mediated immune (CMI) responses to hepatitis C virus (HCV) antigens in adults without seroconversion or viremia are biomarkers for prior transient infection. We investigated HCV-specific CMI responses in seronegative children living with HCV-infected siblings.
METHODS: Children 3-18 years of age living with HCV-infected siblings were screened for HCV antibodies and HCV RNA. Peripheral blood mononuclear cells (PBMCs) were evaluated for HCV-specific CMI responses by interferon γ (IFN-γ) enzyme-linked immunospot assay using 3 recombinant HCV protein antigens. Flow cytometry phenotypically characterized IFN-γ-secreting cells.
RESULTS: Forty-five seronegative children and 5 seropositive viremic siblings had functionally viable PBMCs. Among the 45 seronegative siblings, 15 (33.3%) had positive HCV-specific IFN-γ responses, and subsequent RNA testing revealed that 3 were viremic. Compared with the 5 seropositive viremic children, the median number of HCV-specific spot-forming units was significantly higher in the 12 seronegative aviremic children (P = .002) and in the 3 seronegative viremic children (P = .025). Flow cytometric analysis revealed that IFN-γ was synthesized mainly by CD4(+) T cells.
CONCLUSION: Strong HCV-specific CD4(+) T cell responses were detectable in higher frequency among seronegative, aviremic children compared with persistently infected siblings. Further studies are needed to determine whether these immune responses are protective against HCV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21257736      PMCID: PMC3071132          DOI: 10.1093/infdis/jiq123

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

Authors:  G Missale; R Bertoni; V Lamonaca; A Valli; M Massari; C Mori; M G Rumi; M Houghton; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.

Authors:  P Scognamiglio; D Accapezzato; M A Casciaro; A Cacciani; M Artini; G Bruno; M L Chircu; J Sidney; S Southwood; S Abrignani; A Sette; V Barnaba
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

3.  Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients.

Authors:  J P Bronowicki; D Vetter; G Uhl; H Hudziak; A Uhrlacher; J M Vetter; M Doffoel
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

4.  Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV).

Authors:  U Dittmer; M Spring; H Petry; T Nisslein; P Rieckmann; W Lüke; C Stahl-Hennig; G Hunsmann; W Bodemer
Journal:  J Biotechnol       Date:  1996-01-26       Impact factor: 3.307

5.  HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals.

Authors:  S Mazzoli; D Trabattoni; S Lo Caputo; S Piconi; C Blé; F Meacci; S Ruzzante; A Salvi; F Semplici; R Longhi; M L Fusi; N Tofani; M Biasin; M L Villa; F Mazzotta; M Clerici
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

6.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.

Authors:  K R Fowke; N J Nagelkerke; J Kimani; J N Simonsen; A O Anzala; J J Bwayo; K S MacDonald; E N Ngugi; F A Plummer
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

7.  Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons.

Authors:  M J Koziel; D K Wong; D Dudley; M Houghton; B D Walker
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

8.  Correlates of protection in HIV infection and the progression of HIV infection to AIDS.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Lett       Date:  1996-06       Impact factor: 3.685

9.  Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug use.

Authors:  Anthony J Freeman; Rosemary A Ffrench; Jeffrey J Post; Charles E Harvey; Stuart J Gilmour; Peter A White; George Marinos; Ingrid van Beek; William D Rawlinson; Andrew R Lloyd
Journal:  J Infect Dis       Date:  2004-08-10       Impact factor: 5.226

10.  Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

Authors:  Camilla S Graham; Michael Curry; Qi He; Nezam Afdhal; David Nunes; Catherine Fleming; Robert Horsburgh; Donald Craven; Kenneth E Sherman; Margaret James Koziel
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

View more
  11 in total

1.  Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.

Authors:  Sayed F Abdelwahab; Zainab Zakaria; Maha Sobhy; Eman Rewisha; Mohamed A Mahmoud; Mahmoud A Amer; Mariarosaria Del Sorbo; Stefania Capone; Alfredo Nicosia; Antonella Folgori; Mohamed Hashem; Samer S El-Kamary
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

Review 2.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

3.  Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients.

Authors:  Kenneth E Sherman; Jeremie Guedj; Mohamed Tarek Shata; Jason T Blackard; Susan D Rouster; Mario Castro; Judith Feinberg; Richard K Sterling; Zachary Goodman; Bruce J Aronow; Alan S Perelson
Journal:  Sci Transl Med       Date:  2014-07-23       Impact factor: 17.956

Review 4.  Burden of pediatric hepatitis C.

Authors:  Mortada Hassan El-Shabrawi; Naglaa Mohamed Kamal
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

5.  Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection.

Authors:  Yves Rivière; Thomas Montange; Geneviève Janvier; Caroline Marnata; Ludovic Durrieu; Marie-Laure Chaix; Maria Isaguliants; Odile Launay; Jean-Louis Bresson; Stanislas Pol
Journal:  Virol J       Date:  2012-03-28       Impact factor: 4.099

6.  TH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study.

Authors:  Mona M Rafik; Alaa El-Dien M S Hosny; Khaled O Abdallah; Amal A Abbas; Rania A Abo Shady; Dina A Soliman; Khaled M Nasr El-Din Rakha; Shahira F Alfedawy
Journal:  Virol J       Date:  2013-05-11       Impact factor: 4.099

7.  Two distinct functional patterns of hepatitis C Virus (HCV)-specific T cell responses in seronegative, aviremic patients.

Authors:  Yoon Seok Choi; Jung Eun Lee; Seung Joo Nam; Jung Tak Park; Hyon-Suk Kim; Kyu Hun Choi; Beom Seok Kim; Eui-Cheol Shin
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

8.  Hepatitis C virus-specific cell-mediated immune responses in children born to mothers infected with hepatitis C virus.

Authors:  Samer S El-Kamary; Mohamed Hashem; Doaa A Saleh; Sayed F Abdelwahab; Maha Sobhy; Fatma M Shebl; Michelle D Shardell; G Thomas Strickland; Mohamed Tarek Shata
Journal:  J Pediatr       Date:  2012-08-09       Impact factor: 4.406

9.  Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt.

Authors:  Aline Munier; Diaa Marzouk; Florence Abravanel; Mai El-Daly; Sylvia Taylor; Rasha Mamdouh; Waleed Salah Eldin; Hanan Ezz El-Arab; Dalia Gaber Sos; Mohamed Momen; Omar Okasha; Lenaig Le Fouler; Mostafa El-Hosini; Jacques Izopet; Mona Rafik; Matthew Albert; Mohamed Abdel-Hamid; Mostafa Kamal Mohamed; Elisabeth Delarocque-Astagneau; Arnaud Fontanet
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 10.  Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?

Authors:  Sayed F Abdelwahab
Journal:  Infect Agent Cancer       Date:  2016-05-16       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.